Chongqing Zhifei Biological Products Co Ltd Class A 300122
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 300122 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CNY 34.22
- Day Range
- CNY 33.94–34.58
- 52-Week Range
- CNY 33.51–70.27
- Bid/Ask
- CNY 34.50 / CNY 34.51
- Market Cap
- CNY 82.61 Bil
- Volume/Avg
- 15.1 Mil / 20.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 11.11
- Price/Sales
- 1.54
- Dividend Yield (Trailing)
- 1.46%
- Dividend Yield (Forward)
- 1.46%
- Total Yield
- 1.46%
Company Profile
Chongqing Zhifei Biological Products Co Ltd is a biotech company. It is a Chinese firm and engaged in the research and development, production, Distribution and import and export and sale of vaccines.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Core
- Total Number of Employees
- 6,545
- Website
- http://www.zhifeishengwu.com
Comparables
Valuation
|
Metric
|
300122
|
688319
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.11 | 356.72 | 17.78 |
Price/Book Value | 2.51 | 3.85 | 2.04 |
Price/Sales | 1.54 | 6.88 | 5.63 |
Price/Cash Flow | 14.24 | 289.62 | 16.35 |
Price/Earnings
300122
688319
301207
Financial Strength
|
Metric
|
300122
|
688319
|
301207
|
|---|---|---|---|
Quick Ratio | 1.69 | 2.07 | — |
Current Ratio | 2.26 | 2.27 | — |
Interest Coverage | 143.35 | 4.42 | — |
Quick Ratio
300122
688319
301207
Profitability
|
Metric
|
300122
|
688319
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | 15.03% | −1.80% | 9.39% |
Return on Equity (Normalized) | 24.78% | −3.02% | 11.86% |
Return on Invested Capital (Normalized) | 21.96% | −2.06% | 11.24% |
Return on Assets
300122
688319
301207
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Wdvnkjpw | Lbvr | $593.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Kwrwwwlq | Myxqwv | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Zbdmbccs | Hwbwq | $106.7 Bil | |
MRNA
| Moderna Inc | Drtwqdkq | Wvnw | $50.8 Bil | |
BNTX
| BioNTech SE ADR | Mdfbjntdp | Xkhc | $22.4 Bil | |
ARGX
| argenx SE ADR | Ccmwbssdc | Wlq | $22.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ykzzbppz | Rffgvbw | $19.1 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Khwbsmt | Fhkyvmv | $14.6 Bil | |
INCY
| Incyte Corp | Hdxycrgk | Vkrcbtl | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Gdmdfbgnn | Qnqsps | $12.6 Bil |